November/December 1996

The Year in Review

ByJ. Sanford Schwartz, MD,Colin Gittens

December 1st 1996

Coverage Decisions for Medical Technology by Managed Care: Relationship to Organizational and Physician Payment Characteristics

ByClaudia A. Steiner, MD, MPH,Neil R. Powe,MD, MPH, MBA,Gerard F. Anderson, PhD

December 1st 1996

Childhood Immunizations: Beyond HEDIS

ByThomas M. Ball, MD

December 1st 1996

Implementation of a Clinical Pathway for Cesarean Section

ByScott B. Ransom, DO,James W. Gell, MD,Mathew Harrison,Franklin D. McDonald, MD

December 1st 1996

Six HMOs in Search of a Study: Comments on Two Papers by Horn et al

ByMark S. Blumberg, MD

December 1st 1996

Homecare Therapy: A Cost-Effective Alternative Approach to the Management of Advanced Heart Failure

ByLisa M. Ryan, RN, CCRN

December 1st 1996

The Cholesterol Population Model: US Population Requirements for Treatment of Hypercholesterolemia

ByRobert S. Epstein, MD, MS,Susan Garrahan,Linda Nelsen, MS,Pamela Laber,Eve Slater, MD,Marc L. Berger, MD

December 1st 1996

The Economic and Health-Related Quality of Life Impact of Epilepsy

ByJan D. Hirsch, PhD,L. Ann Tanner, RPh, MPH

December 1st 1996

Telecomputing as a Tool to Increase Consumer Participation in Managed Care

ByJeremy Nobel, MD, MPH,Jeremy Brody, SM

December 1st 1996

Impact of Oral Sumatriptan on Workplace Productivity, Health-Related Quality of Life, Healthcare Use, and Patient Satisfaction with Medication in Nurses with Migraine

ByJames U. Adelman, MD,Marc Sharfman, MD,Rodney Johnson, MD,David Miller, PhD,Bill Clements, MS,D. Gayla Pait, MS,Donna Gutterman, Pharm

December 1st 1996

Disease Management: Has Anyone Managed to Make It Work?

ByJoseph J. Hreben, MPA

December 1st 1996

A Pharmacoeconomic Assessment of Torsemide in the Treatment of Congestive Heart Failure

ByAlan H. Heaton, PharmD,Jeffrey P. Trotter, MM

December 1st 1996

Use of Ultrasound in Low-Risk Intrauterine Pregnancy

ByMindy Wiser-Estin, MD,James A. Austin, MD, MBA,Robin L. Smith, MD

December 1st 1996

The Impact of Managed Care on Continuing Medical Education

ByRobert S. Pyatt, MD

December 1st 1996

November/December 1996

The Year in Review

Coverage Decisions for Medical Technology by Managed Care: Relationship to Organizational and Physician Payment Characteristics

Childhood Immunizations: Beyond HEDIS

Implementation of a Clinical Pathway for Cesarean Section

Six HMOs in Search of a Study: Comments on Two Papers by Horn et al

Homecare Therapy: A Cost-Effective Alternative Approach to the Management of Advanced Heart Failure

The Cholesterol Population Model: US Population Requirements for Treatment of Hypercholesterolemia

The Economic and Health-Related Quality of Life Impact of Epilepsy

Telecomputing as a Tool to Increase Consumer Participation in Managed Care

Impact of Oral Sumatriptan on Workplace Productivity, Health-Related Quality of Life, Healthcare Use, and Patient Satisfaction with Medication in Nurses with Migraine

Disease Management: Has Anyone Managed to Make It Work?

A Pharmacoeconomic Assessment of Torsemide in the Treatment of Congestive Heart Failure

Use of Ultrasound in Low-Risk Intrauterine Pregnancy

The Impact of Managed Care on Continuing Medical Education

Trending on AJMC

In CLL, Fixed-Duration Venetoclax Combos Are Equal to Continuous Ibrutinib in Head-to-Head Comparison

Fixed-Duration Epcoritamab Plus Chemotherapy Yields Response, Remissions in DLBCL

ASH 2025 Offers Data That Could Make Novel Therapies More Accessible

Making the Genetic Models Match the Ancestry of Patient Populations

Once-Monthly Maridebart Cafraglutide Shows Up to 16% Weight Loss